Integrative Cancer Solutions with Dr. Karlfeldt

Dr. Stephen Petteruti │ Skip the Prostate Biopsy: PSA, MRI & Testosterone Therapy Explained

Integrative Cancer Solutions with Dr. Karlfeldt

Show Notes

What if everything men are told about a prostate cancer diagnosis, biopsy first, surgery next, is built on evidence that was never actually there? In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. Stephen Petteruti, board certified family physician and author of Fight Cancer Like a Man, to break down the 2023 New England Journal of Medicine study that found no survival difference between surgery, radiation, and doing nothing at all for early stage prostate cancer. Dr. Petteruti explains why he stopped recommending biopsies, how a needle can spread the very cancer it's meant to detect, and why watching PSA and MRI trends over time is often safer than rushing into treatment. He also covers the overlooked role of testosterone in prostate cancer care, including bipolar androgen therapy, and makes the case for tracking the disease like a chronic condition instead of chasing a cure that costs a man his vitality.

If you or someone you love is facing a prostate cancer diagnosis, or just navigating an elevated PSA, this conversation lays out the questions worth asking before agreeing to anything.

Key Takeaways:

0:00 Introduction 2:33 The prostate trial that shattered the surgery-first model 5:19 Why a biopsy can spread the very cancer it's meant to find 8:23 Castration's hidden cost on testosterone and quality of life 17:12 Tracking prostate cancer with MRI and PSA instead of biopsy 21:58 Repurposed drugs and why DIY protocols backfire 38:10 BAM therapy: using testosterone as a weapon against advanced cancer

Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902

Resources:

Fight Cancer Like a Man (book) - https://www.intellectualmedicine.com/dr-stephen-petteruti-books Intellectual Medicine, Dr. Petteruti's practice - https://www.intellectualmedicine.com/ The Prostate Protocol - https://assets.ctfassets.net/psmhuxrqomif/4iFYGN6rh0cloFTQyxdit9/a2c3e8e20e335df0ad22f70ca0e0af48/the-prostate-protocol-pdf.pdf ProtecT Trial, New England Journal of Medicine, 2023 - https://www.nejm.org/doi/full/10.1056/NEJMoa2214122 Johns Hopkins Bipolar Androgen Therapy Research - https://www.hopkinsmedicine.org/news/articles/2023/12/bipolar-androgen-therapy-trials-under-way

Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions.

More from Integrative Cancer Solutions with Dr. Karlfeldt

Oct 21, 2026

What if a breast cancer diagnosis is rarely the emergency it feels like, and the time you take next matters most?

Oct 14, 2026

Which peptides belong in a cancer protocol, and which ones should wait?

Oct 7, 2026

What happens when the surgeon who has spent his career saving other people's lives finally has to save his own? In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. James C. Wittig, a nationally recognized orthopedic oncologist and sarcoma surgeon and the Founder and CEO of Mandala Medical Group, with roughly 10,000 procedures behind him. He explains why sarcoma in kids and teens so often gets dismissed as a sports injury or growing pains, and how limb-sparing surgery became the standard for most patients. Then he gets personal: thirty years of five-hour nights and eighty-hour weeks that ended in kidney failure and three stents. That experience is why he now brings hypnosis, meditation, neurofeedback and root cause testing like fasting insulin into cancer care. If you or someone you love is facing cancer, this conversation shows what whole-person care can look like from a surgeon who has been on both sides of it. Key Takeaways: Why sarcoma in children and teens gets missed as a sports injury or growing pains How chemotherapy response predicts osteosarcoma survival A sarcoma surgeon's wake-up call: 80-hour weeks, kidney failure and three stents Hypnosis, meditation and neurofeedback for stress and immune health during cancer treatment Fasting insulin, gut health and sugar as root causes in cancer care Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902

Sep 30, 2026

What if the last piece of your cancer won't go away because it isn't physical at all? In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. Dana Flavin, a pharmacologist, toxicologist, biochemist and physician with 58 semesters of training behind her and more than 30 years of treating cancer patients around the world. Dana never set out to treat anyone. That changed in 1992, when friends in Ireland asked her to help a woman with advanced cervical cancer, no money and no insurance. Six months later the tumor was gone, and Dana has spent the decades since mapping how foods, nutrients, repurposed drugs and emotions each act on cancer biochemistry. She explains why a single-target drug so often stops working, and how shiitake and maitake mushrooms knock down the same immune-suppressing cells as cimetidine. She covers why a low-methionine, low-sugar, plant-based diet matters, and shares a stage 4 prostate cancer case where PSA dropped from 5,000 to 24.4 in 10 weeks. She also tells the story of a breast cancer patient whose last bit of tumor only cleared after she learned to love herself. If you or someone you love is fighting cancer, or working hard to keep it from coming back, this conversation gives you a lot to take to your care team. Key Takeaways: Why combination cancer therapy works when single-target drugs lead to resistance, from a colon cancer case with liver, lung and lymph metastases How shiitake and maitake mushrooms and cimetidine lower myeloid-derived suppressor cells so the immune system can recover A plant-based, low-methionine, low-sugar diet for cancer, plus cherries, raspberries and organic food Off-label drugs in a stage 4 prostate cancer case: PSA from 5,000 to 24.4 in 10 weeks with itraconazole, ivermectin, mebendazole and low dose naltrexone Emotional healing, forgiveness and staying in remission, and why unresolved hurt can bring cancer back

Sep 16, 2026

What if a blue-green algae could help your cells fight cancer the same way your own immune system does? In this episode of Integrative Cancer Solutions, Dr. K talks with Catharine Arnston, PhD, founder of ENERGYbits and author of the upcoming book Love Your Health to Bits with Algae. Catharine has spent years researching spirulina and chlorella, and she walks through why she sees cancer as a metabolic disease, one driven by damaged mitochondria, acidic cells, and the glucose that feeds tumor growth, a process known as the Warburg effect. She breaks down how superoxide dismutase protects your mitochondria from free radical damage, how chlorella clears the toxins that block your cell receptors, and how the blue pigment in spirulina called phycocyanin can trigger cancer cells to self-destruct while leaving healthy cells alone. If you or someone you love is trying to prevent, treat, or recover from cancer, this conversation gives you nutritional tools you can start using today. Key Takeaways: Why cancer is increasingly understood as a metabolic disease driven by the Warburg effect and glucose-fueled cell growth How spirulina's superoxide dismutase (SOD) content protects mitochondria from free radical damage as natural SOD levels decline with age Chlorella's detoxifying effect on cell receptors, and why clearing out cell-blocking toxins matters for nutrient absorption Phycocyanin, the blue pigment unique to spirulina, and its documented anti-angiogenesis effect and role in triggering apoptosis in cancer cells Why cutting simple sugars and carbs and increasing movement lowers the glucose available to feed cancer cells, tracked through the glucose ketone index (GKI)

See all episodes →